nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—CYP19A1—Paclitaxel—lung cancer	0.175	1	CbGbCtD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—lung cancer	0.000362	0.00164	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—SRC—lung cancer	0.000357	0.00162	CbGpPWpGaD
Cyproterone acetate—NR3C1—Circadian Clock—EP300—lung cancer	0.000356	0.00161	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—AVP—lung cancer	0.000351	0.00159	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—lung cancer	0.000348	0.00158	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CCND1—lung cancer	0.000347	0.00157	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—JUN—lung cancer	0.000346	0.00157	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—GSTM1—lung cancer	0.000346	0.00157	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—EP300—lung cancer	0.000344	0.00156	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	0.000344	0.00156	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CXCL8—lung cancer	0.000342	0.00155	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—GSTM1—lung cancer	0.000341	0.00155	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—RARB—lung cancer	0.00034	0.00154	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CDKN1A—lung cancer	0.000336	0.00152	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—PTEN—lung cancer	0.000335	0.00152	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—HES1—lung cancer	0.000332	0.0015	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NPPA—lung cancer	0.000331	0.0015	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL10—lung cancer	0.00033	0.0015	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP1A1—lung cancer	0.000328	0.00149	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL2—lung cancer	0.000327	0.00148	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—HNRNPA2B1—lung cancer	0.000327	0.00148	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MMP1—lung cancer	0.000326	0.00148	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP1A1—lung cancer	0.000323	0.00147	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—MDM2—lung cancer	0.000323	0.00146	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—HIF1A—lung cancer	0.000322	0.00146	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—SKI—lung cancer	0.000321	0.00146	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—EP300—lung cancer	0.000319	0.00145	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CCND1—lung cancer	0.000319	0.00145	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—JUN—lung cancer	0.000318	0.00144	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	0.000316	0.00143	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—BRAF—lung cancer	0.000311	0.00141	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—SRC—lung cancer	0.00031	0.00141	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—MMP9—lung cancer	0.00031	0.0014	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CASP8—lung cancer	0.000309	0.0014	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—PTEN—lung cancer	0.000308	0.0014	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—RB1—lung cancer	0.000306	0.00139	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CDH1—lung cancer	0.000305	0.00138	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—lung cancer	0.000303	0.00137	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—lung cancer	0.000302	0.00137	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—lung cancer	0.0003	0.00136	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL6R—lung cancer	0.0003	0.00136	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—STAT3—lung cancer	0.000299	0.00136	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CREBBP—lung cancer	0.000299	0.00136	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—KHSRP—lung cancer	0.000299	0.00136	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—EP300—lung cancer	0.000294	0.00133	CbGpPWpGaD
Cyproterone acetate—Liver function test abnormal—Doxorubicin—lung cancer	0.000293	0.000486	CcSEcCtD
Cyproterone acetate—Dyspnoea—Cisplatin—lung cancer	0.000293	0.000485	CcSEcCtD
Cyproterone acetate—Skin disorder—Etoposide—lung cancer	0.000293	0.000484	CcSEcCtD
Cyproterone acetate—Erectile dysfunction—Methotrexate—lung cancer	0.000292	0.000483	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Etoposide—lung cancer	0.000291	0.000482	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Gemcitabine—lung cancer	0.000291	0.000481	CcSEcCtD
Cyproterone acetate—Shock—Paclitaxel—lung cancer	0.000291	0.000481	CcSEcCtD
Cyproterone acetate—Dizziness—Vinorelbine—lung cancer	0.00029	0.00048	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Paclitaxel—lung cancer	0.00029	0.000479	CcSEcCtD
Cyproterone acetate—Photosensitivity reaction—Methotrexate—lung cancer	0.00029	0.000479	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Paclitaxel—lung cancer	0.000289	0.000478	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—COL4A3BP—lung cancer	0.000288	0.00131	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AZIN2—lung cancer	0.000288	0.00131	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL2—lung cancer	0.000288	0.00131	CbGpPWpGaD
Cyproterone acetate—Tachycardia—Paclitaxel—lung cancer	0.000288	0.000477	CcSEcCtD
Cyproterone acetate—Breast disorder—Doxorubicin—lung cancer	0.000287	0.000475	CcSEcCtD
Cyproterone acetate—Anorexia—Etoposide—lung cancer	0.000287	0.000475	CcSEcCtD
Cyproterone acetate—Skin disorder—Paclitaxel—lung cancer	0.000287	0.000475	CcSEcCtD
Cyproterone acetate—Abdominal pain—Irinotecan—lung cancer	0.000286	0.000474	CcSEcCtD
Cyproterone acetate—Body temperature increased—Irinotecan—lung cancer	0.000286	0.000474	CcSEcCtD
Cyproterone acetate—Aspartate aminotransferase increased—Doxorubicin—lung cancer	0.000286	0.000474	CcSEcCtD
Cyproterone acetate—Decreased appetite—Cisplatin—lung cancer	0.000286	0.000473	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Paclitaxel—lung cancer	0.000285	0.000472	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Cisplatin—lung cancer	0.000284	0.00047	CcSEcCtD
Cyproterone acetate—Anaemia—Docetaxel—lung cancer	0.000283	0.000469	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—lung cancer	0.000283	0.00128	CbGpPWpGaD
Cyproterone acetate—Anorexia—Paclitaxel—lung cancer	0.000281	0.000466	CcSEcCtD
Cyproterone acetate—Hypotension—Etoposide—lung cancer	0.000281	0.000466	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—JUN—lung cancer	0.00028	0.00127	CbGpPWpGaD
Cyproterone acetate—Alanine aminotransferase increased—Doxorubicin—lung cancer	0.00028	0.000464	CcSEcCtD
Cyproterone acetate—Muscular weakness—Doxorubicin—lung cancer	0.00028	0.000464	CcSEcCtD
Cyproterone acetate—Vomiting—Vinorelbine—lung cancer	0.000279	0.000462	CcSEcCtD
Cyproterone acetate—Body temperature increased—Gemcitabine—lung cancer	0.000279	0.000461	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—EIF2B4—lung cancer	0.000278	0.00126	CbGpPWpGaD
Cyproterone acetate—Renal failure—Methotrexate—lung cancer	0.000278	0.00046	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—HIF1A—lung cancer	0.000278	0.00126	CbGpPWpGaD
Cyproterone acetate—Rash—Vinorelbine—lung cancer	0.000277	0.000458	CcSEcCtD
Cyproterone acetate—Dermatitis—Vinorelbine—lung cancer	0.000277	0.000458	CcSEcCtD
Cyproterone acetate—Hypotension—Paclitaxel—lung cancer	0.000276	0.000457	CcSEcCtD
Cyproterone acetate—Headache—Vinorelbine—lung cancer	0.000275	0.000455	CcSEcCtD
Cyproterone acetate—Syncope—Docetaxel—lung cancer	0.000275	0.000455	CcSEcCtD
Cyproterone acetate—Asthma—Doxorubicin—lung cancer	0.000275	0.000455	CcSEcCtD
Cyproterone acetate—Leukopenia—Docetaxel—lung cancer	0.000275	0.000454	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—lung cancer	0.000274	0.00125	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—APC—lung cancer	0.000274	0.00125	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—EGFR—lung cancer	0.000272	0.00123	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—lung cancer	0.000272	0.00123	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	0.000271	0.00123	CbGpPWpGaD
Cyproterone acetate—Sweating—Methotrexate—lung cancer	0.000271	0.000449	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Cisplatin—lung cancer	0.000271	0.000448	CcSEcCtD
Cyproterone acetate—Haematuria—Methotrexate—lung cancer	0.00027	0.000446	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Docetaxel—lung cancer	0.00027	0.000446	CcSEcCtD
Cyproterone acetate—Pancreatitis—Doxorubicin—lung cancer	0.000269	0.000446	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	0.000269	0.00122	CbGpPWpGaD
Cyproterone acetate—Dyspnoea—Etoposide—lung cancer	0.000269	0.000444	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—BRAF—lung cancer	0.000268	0.00122	CbGpPWpGaD
Cyproterone acetate—Cough—Docetaxel—lung cancer	0.000268	0.000443	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Methotrexate—lung cancer	0.000268	0.000443	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Irinotecan—lung cancer	0.000267	0.000441	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CASP8—lung cancer	0.000265	0.0012	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—RB1—lung cancer	0.000263	0.00119	CbGpPWpGaD
Cyproterone acetate—Dyspnoea—Paclitaxel—lung cancer	0.000263	0.000436	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CDH1—lung cancer	0.000262	0.00119	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Etoposide—lung cancer	0.000262	0.000433	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—RB1—lung cancer	0.000262	0.00119	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—lung cancer	0.000261	0.00118	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—EIF2B5—lung cancer	0.000261	0.00118	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—AKT1—lung cancer	0.000261	0.00118	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MDM2—lung cancer	0.000261	0.00118	CbGpPWpGaD
Cyproterone acetate—Nausea—Vinorelbine—lung cancer	0.000261	0.000431	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	0.00026	0.00118	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal disorder—Etoposide—lung cancer	0.00026	0.00043	CcSEcCtD
Cyproterone acetate—Dyspepsia—Paclitaxel—lung cancer	0.00026	0.00043	CcSEcCtD
Cyproterone acetate—Body temperature increased—Cisplatin—lung cancer	0.00026	0.00043	CcSEcCtD
Cyproterone acetate—Asthenia—Irinotecan—lung cancer	0.00026	0.00043	CcSEcCtD
Cyproterone acetate—Fatigue—Etoposide—lung cancer	0.00026	0.00043	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000259	0.000429	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—EP300—lung cancer	0.000259	0.00117	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—RARB—lung cancer	0.000258	0.00117	CbGpPWpGaD
Cyproterone acetate—Constipation—Etoposide—lung cancer	0.000258	0.000426	CcSEcCtD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—lung cancer	0.000257	0.00117	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Paclitaxel—lung cancer	0.000257	0.000425	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—MYC—lung cancer	0.000256	0.00116	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	0.000256	0.00116	CbGpPWpGaD
Cyproterone acetate—Haemoglobin—Methotrexate—lung cancer	0.000255	0.000422	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000255	0.000422	CcSEcCtD
Cyproterone acetate—Fatigue—Paclitaxel—lung cancer	0.000255	0.000421	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	0.000254	0.00115	CbGpPWpGaD
Cyproterone acetate—Haemorrhage—Methotrexate—lung cancer	0.000254	0.00042	CcSEcCtD
Cyproterone acetate—Hepatitis—Methotrexate—lung cancer	0.000254	0.00042	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MTOR—lung cancer	0.000254	0.00115	CbGpPWpGaD
Cyproterone acetate—Pollakiuria—Doxorubicin—lung cancer	0.000254	0.00042	CcSEcCtD
Cyproterone acetate—Asthenia—Gemcitabine—lung cancer	0.000253	0.000419	CcSEcCtD
Cyproterone acetate—Constipation—Paclitaxel—lung cancer	0.000253	0.000418	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NPPA—lung cancer	0.000251	0.00114	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NOTCH3—lung cancer	0.000251	0.00114	CbGpPWpGaD
Cyproterone acetate—Photosensitivity reaction—Doxorubicin—lung cancer	0.000251	0.000415	CcSEcCtD
Cyproterone acetate—Oedema—Docetaxel—lung cancer	0.00025	0.000414	CcSEcCtD
Cyproterone acetate—Weight increased—Doxorubicin—lung cancer	0.00025	0.000414	CcSEcCtD
Cyproterone acetate—Pruritus—Gemcitabine—lung cancer	0.00025	0.000413	CcSEcCtD
Cyproterone acetate—Weight decreased—Doxorubicin—lung cancer	0.000249	0.000411	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Etoposide—lung cancer	0.000248	0.000411	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—HNRNPA2B1—lung cancer	0.000248	0.00112	CbGpPWpGaD
Cyproterone acetate—Hyperglycaemia—Doxorubicin—lung cancer	0.000248	0.00041	CcSEcCtD
Cyproterone acetate—Diarrhoea—Irinotecan—lung cancer	0.000248	0.00041	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Etoposide—lung cancer	0.000246	0.000407	CcSEcCtD
Cyproterone acetate—Shock—Docetaxel—lung cancer	0.000246	0.000407	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Docetaxel—lung cancer	0.000245	0.000406	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—ATP5H—lung cancer	0.000245	0.00111	CbGpPWpGaD
Cyproterone acetate—Thrombocytopenia—Docetaxel—lung cancer	0.000245	0.000405	CcSEcCtD
Cyproterone acetate—Visual impairment—Methotrexate—lung cancer	0.000245	0.000405	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—POMC—lung cancer	0.000244	0.00111	CbGpPWpGaD
Cyproterone acetate—Tachycardia—Docetaxel—lung cancer	0.000244	0.000404	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Paclitaxel—lung cancer	0.000243	0.000403	CcSEcCtD
Cyproterone acetate—Skin disorder—Docetaxel—lung cancer	0.000243	0.000402	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	0.000243	0.0011	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Cisplatin—lung cancer	0.000242	0.000401	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Paclitaxel—lung cancer	0.000241	0.0004	CcSEcCtD
Cyproterone acetate—Diarrhoea—Gemcitabine—lung cancer	0.000241	0.000399	CcSEcCtD
Cyproterone acetate—Renal failure—Doxorubicin—lung cancer	0.000241	0.000398	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Methotrexate—lung cancer	0.00024	0.000397	CcSEcCtD
Cyproterone acetate—Dizziness—Irinotecan—lung cancer	0.000239	0.000396	CcSEcCtD
Cyproterone acetate—Urticaria—Etoposide—lung cancer	0.000239	0.000396	CcSEcCtD
Cyproterone acetate—Jaundice—Doxorubicin—lung cancer	0.000239	0.000395	CcSEcCtD
Cyproterone acetate—Anorexia—Docetaxel—lung cancer	0.000239	0.000395	CcSEcCtD
Cyproterone acetate—Abdominal pain—Etoposide—lung cancer	0.000238	0.000394	CcSEcCtD
Cyproterone acetate—Body temperature increased—Etoposide—lung cancer	0.000238	0.000394	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—JUNB—lung cancer	0.000238	0.00108	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.000238	0.00108	CbGpPWpGaD
Cyproterone acetate—Eye disorder—Methotrexate—lung cancer	0.000237	0.000393	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—DICER1—lung cancer	0.000236	0.00107	CbGpPWpGaD
Cyproterone acetate—Asthenia—Cisplatin—lung cancer	0.000236	0.00039	CcSEcCtD
Cyproterone acetate—Sweating—Doxorubicin—lung cancer	0.000235	0.000389	CcSEcCtD
Cyproterone acetate—Urticaria—Paclitaxel—lung cancer	0.000235	0.000388	CcSEcCtD
Cyproterone acetate—Hypotension—Docetaxel—lung cancer	0.000234	0.000387	CcSEcCtD
Cyproterone acetate—Haematuria—Doxorubicin—lung cancer	0.000234	0.000386	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CASP3—lung cancer	0.000233	0.00106	CbGpPWpGaD
Cyproterone acetate—Abdominal pain—Paclitaxel—lung cancer	0.000233	0.000386	CcSEcCtD
Cyproterone acetate—Body temperature increased—Paclitaxel—lung cancer	0.000233	0.000386	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—lung cancer	0.000232	0.00105	CbGpPWpGaD
Cyproterone acetate—Hepatobiliary disease—Doxorubicin—lung cancer	0.000232	0.000383	CcSEcCtD
Cyproterone acetate—Angiopathy—Methotrexate—lung cancer	0.00023	0.000381	CcSEcCtD
Cyproterone acetate—Vomiting—Irinotecan—lung cancer	0.00023	0.000381	CcSEcCtD
Cyproterone acetate—Immune system disorder—Methotrexate—lung cancer	0.000229	0.000379	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Methotrexate—lung cancer	0.000229	0.000379	CcSEcCtD
Cyproterone acetate—Rash—Irinotecan—lung cancer	0.000228	0.000378	CcSEcCtD
Cyproterone acetate—Dermatitis—Irinotecan—lung cancer	0.000228	0.000377	CcSEcCtD
Cyproterone acetate—Chills—Methotrexate—lung cancer	0.000228	0.000377	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—lung cancer	0.000228	0.00103	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CASP3—lung cancer	0.000227	0.00103	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL6R—lung cancer	0.000227	0.00103	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CCND1—lung cancer	0.000227	0.00103	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CREBBP—lung cancer	0.000227	0.00103	CbGpPWpGaD
Cyproterone acetate—Headache—Irinotecan—lung cancer	0.000227	0.000375	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—JUN—lung cancer	0.000227	0.00103	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—KHSRP—lung cancer	0.000227	0.00103	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	0.000225	0.00102	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Cisplatin—lung cancer	0.000225	0.000372	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MDM2—lung cancer	0.000224	0.00102	CbGpPWpGaD
Cyproterone acetate—Alopecia—Methotrexate—lung cancer	0.000224	0.000371	CcSEcCtD
Cyproterone acetate—Vomiting—Gemcitabine—lung cancer	0.000224	0.000371	CcSEcCtD
Cyproterone acetate—Dyspnoea—Docetaxel—lung cancer	0.000223	0.000369	CcSEcCtD
Cyproterone acetate—Mental disorder—Methotrexate—lung cancer	0.000222	0.000368	CcSEcCtD
Cyproterone acetate—Rash—Gemcitabine—lung cancer	0.000222	0.000368	CcSEcCtD
Cyproterone acetate—Dermatitis—Gemcitabine—lung cancer	0.000222	0.000368	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Etoposide—lung cancer	0.000222	0.000367	CcSEcCtD
Cyproterone acetate—Malnutrition—Methotrexate—lung cancer	0.000221	0.000366	CcSEcCtD
Cyproterone acetate—Haemoglobin—Doxorubicin—lung cancer	0.000221	0.000366	CcSEcCtD
Cyproterone acetate—Headache—Gemcitabine—lung cancer	0.000221	0.000366	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—JUN—lung cancer	0.000221	0.001	CbGpPWpGaD
Cyproterone acetate—Dyspepsia—Docetaxel—lung cancer	0.00022	0.000365	CcSEcCtD
Cyproterone acetate—Hepatitis—Doxorubicin—lung cancer	0.00022	0.000364	CcSEcCtD
Cyproterone acetate—Haemorrhage—Doxorubicin—lung cancer	0.00022	0.000364	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—PTEN—lung cancer	0.000219	0.000995	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PLBD1—lung cancer	0.000219	0.000992	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MTOR—lung cancer	0.000218	0.000991	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Docetaxel—lung cancer	0.000218	0.00036	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Paclitaxel—lung cancer	0.000218	0.00036	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	0.000216	0.000981	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal disorder—Docetaxel—lung cancer	0.000216	0.000358	CcSEcCtD
Cyproterone acetate—Asthenia—Etoposide—lung cancer	0.000216	0.000358	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Doxorubicin—lung cancer	0.000216	0.000358	CcSEcCtD
Cyproterone acetate—Fatigue—Docetaxel—lung cancer	0.000216	0.000357	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	0.000215	0.000977	CbGpPWpGaD
Cyproterone acetate—Nausea—Irinotecan—lung cancer	0.000215	0.000356	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	0.000215	0.000975	CbGpPWpGaD
Cyproterone acetate—Constipation—Docetaxel—lung cancer	0.000214	0.000354	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	0.000213	0.000967	CbGpPWpGaD
Cyproterone acetate—Pruritus—Etoposide—lung cancer	0.000213	0.000353	CcSEcCtD
Cyproterone acetate—Visual impairment—Doxorubicin—lung cancer	0.000212	0.000351	CcSEcCtD
Cyproterone acetate—Asthenia—Paclitaxel—lung cancer	0.000212	0.000351	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TP53—lung cancer	0.00021	0.000953	CbGpPWpGaD
Cyproterone acetate—Nausea—Gemcitabine—lung cancer	0.000209	0.000347	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—EP300—lung cancer	0.000209	0.000949	CbGpPWpGaD
Cyproterone acetate—Vomiting—Cisplatin—lung cancer	0.000209	0.000346	CcSEcCtD
Cyproterone acetate—Pruritus—Paclitaxel—lung cancer	0.000209	0.000346	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	0.000208	0.000945	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—lung cancer	0.000208	0.000944	CbGpPWpGaD
Cyproterone acetate—Erythema multiforme—Doxorubicin—lung cancer	0.000208	0.000344	CcSEcCtD
Cyproterone acetate—Rash—Cisplatin—lung cancer	0.000207	0.000343	CcSEcCtD
Cyproterone acetate—Dermatitis—Cisplatin—lung cancer	0.000207	0.000343	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Docetaxel—lung cancer	0.000206	0.000341	CcSEcCtD
Cyproterone acetate—Diarrhoea—Etoposide—lung cancer	0.000206	0.000341	CcSEcCtD
Cyproterone acetate—Eye disorder—Doxorubicin—lung cancer	0.000205	0.00034	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Methotrexate—lung cancer	0.000205	0.000339	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Docetaxel—lung cancer	0.000205	0.000339	CcSEcCtD
Cyproterone acetate—Anaemia—Methotrexate—lung cancer	0.000204	0.000338	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—SKI—lung cancer	0.000204	0.000925	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—EP300—lung cancer	0.000204	0.000924	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Paclitaxel—lung cancer	0.000202	0.000334	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—lung cancer	0.000201	0.000911	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HSD17B10—lung cancer	0.0002	0.000907	CbGpPWpGaD
Cyproterone acetate—Angiopathy—Doxorubicin—lung cancer	0.000199	0.00033	CcSEcCtD
Cyproterone acetate—Malaise—Methotrexate—lung cancer	0.000199	0.00033	CcSEcCtD
Cyproterone acetate—Dizziness—Etoposide—lung cancer	0.000199	0.00033	CcSEcCtD
Cyproterone acetate—Immune system disorder—Doxorubicin—lung cancer	0.000199	0.000329	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Doxorubicin—lung cancer	0.000198	0.000328	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—EIF2B5—lung cancer	0.000198	0.000899	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—VEGFA—lung cancer	0.000198	0.000899	CbGpPWpGaD
Cyproterone acetate—Abdominal pain—Docetaxel—lung cancer	0.000198	0.000327	CcSEcCtD
Cyproterone acetate—Body temperature increased—Docetaxel—lung cancer	0.000198	0.000327	CcSEcCtD
Cyproterone acetate—Leukopenia—Methotrexate—lung cancer	0.000198	0.000327	CcSEcCtD
Cyproterone acetate—Chills—Doxorubicin—lung cancer	0.000197	0.000326	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—lung cancer	0.000196	0.000887	CbGpPWpGaD
Cyproterone acetate—Dizziness—Paclitaxel—lung cancer	0.000195	0.000323	CcSEcCtD
Cyproterone acetate—Nausea—Cisplatin—lung cancer	0.000195	0.000323	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—JUN—lung cancer	0.000195	0.000885	CbGpPWpGaD
Cyproterone acetate—Alopecia—Doxorubicin—lung cancer	0.000194	0.000321	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	0.000193	0.000877	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.000193	0.000875	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—AKT1—lung cancer	0.000193	0.000875	CbGpPWpGaD
Cyproterone acetate—Cough—Methotrexate—lung cancer	0.000193	0.000319	CcSEcCtD
Cyproterone acetate—Mental disorder—Doxorubicin—lung cancer	0.000193	0.000319	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL6—lung cancer	0.000192	0.000872	CbGpPWpGaD
Cyproterone acetate—Vomiting—Etoposide—lung cancer	0.000191	0.000317	CcSEcCtD
Cyproterone acetate—Malnutrition—Doxorubicin—lung cancer	0.000191	0.000317	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NOTCH3—lung cancer	0.000191	0.000864	CbGpPWpGaD
Cyproterone acetate—Rash—Etoposide—lung cancer	0.00019	0.000314	CcSEcCtD
Cyproterone acetate—Dermatitis—Etoposide—lung cancer	0.00019	0.000314	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—lung cancer	0.000189	0.000856	CbGpPWpGaD
Cyproterone acetate—Headache—Etoposide—lung cancer	0.000189	0.000312	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	0.000188	0.000854	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—CDKN1A—lung cancer	0.000188	0.000853	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	0.000188	0.000852	CbGpPWpGaD
Cyproterone acetate—Tension—Doxorubicin—lung cancer	0.000188	0.000311	CcSEcCtD
Cyproterone acetate—Vomiting—Paclitaxel—lung cancer	0.000188	0.000311	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000187	0.000309	CcSEcCtD
Cyproterone acetate—Rash—Paclitaxel—lung cancer	0.000186	0.000308	CcSEcCtD
Cyproterone acetate—Dermatitis—Paclitaxel—lung cancer	0.000186	0.000308	CcSEcCtD
Cyproterone acetate—Discomfort—Methotrexate—lung cancer	0.000186	0.000308	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—CKB—lung cancer	0.000186	0.000843	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—lung cancer	0.000185	0.00084	CbGpPWpGaD
Cyproterone acetate—Headache—Paclitaxel—lung cancer	0.000185	0.000306	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Docetaxel—lung cancer	0.000184	0.000305	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MYC—lung cancer	0.000182	0.000827	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	0.000182	0.000826	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	0.000182	0.000824	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—JUNB—lung cancer	0.00018	0.000818	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.00018	0.000818	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—EP300—lung cancer	0.00018	0.000816	CbGpPWpGaD
Cyproterone acetate—Asthenia—Docetaxel—lung cancer	0.00018	0.000297	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—DICER1—lung cancer	0.000179	0.000813	CbGpPWpGaD
Cyproterone acetate—Nausea—Etoposide—lung cancer	0.000179	0.000296	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—EGFR—lung cancer	0.000178	0.000809	CbGpPWpGaD
Cyproterone acetate—Ill-defined disorder—Doxorubicin—lung cancer	0.000178	0.000294	CcSEcCtD
Cyproterone acetate—Pruritus—Docetaxel—lung cancer	0.000177	0.000293	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Methotrexate—lung cancer	0.000177	0.000293	CcSEcCtD
Cyproterone acetate—Anaemia—Doxorubicin—lung cancer	0.000177	0.000293	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Methotrexate—lung cancer	0.000177	0.000292	CcSEcCtD
Cyproterone acetate—Agitation—Doxorubicin—lung cancer	0.000176	0.000291	CcSEcCtD
Cyproterone acetate—Nausea—Paclitaxel—lung cancer	0.000175	0.00029	CcSEcCtD
Cyproterone acetate—Skin disorder—Methotrexate—lung cancer	0.000175	0.00029	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—GSTM2—lung cancer	0.000175	0.000793	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CNDP2—lung cancer	0.000175	0.000793	CbGpPWpGaD
Cyproterone acetate—Hyperhidrosis—Methotrexate—lung cancer	0.000174	0.000289	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	0.000173	0.000786	CbGpPWpGaD
Cyproterone acetate—Malaise—Doxorubicin—lung cancer	0.000173	0.000286	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CASP3—lung cancer	0.000173	0.000783	CbGpPWpGaD
Cyproterone acetate—Anorexia—Methotrexate—lung cancer	0.000172	0.000285	CcSEcCtD
Cyproterone acetate—Syncope—Doxorubicin—lung cancer	0.000172	0.000284	CcSEcCtD
Cyproterone acetate—Leukopenia—Doxorubicin—lung cancer	0.000171	0.000283	CcSEcCtD
Cyproterone acetate—Diarrhoea—Docetaxel—lung cancer	0.000171	0.000283	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—lung cancer	0.00017	0.000773	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MTMR3—lung cancer	0.00017	0.000771	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL6—lung cancer	0.000169	0.000768	CbGpPWpGaD
Cyproterone acetate—Hypotension—Methotrexate—lung cancer	0.000169	0.000279	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	0.000169	0.000765	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—KRAS—lung cancer	0.000168	0.000764	CbGpPWpGaD
Cyproterone acetate—Loss of consciousness—Doxorubicin—lung cancer	0.000168	0.000278	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—STAT3—lung cancer	0.000168	0.000761	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—JUN—lung cancer	0.000168	0.00076	CbGpPWpGaD
Cyproterone acetate—Cough—Doxorubicin—lung cancer	0.000167	0.000276	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—PGAM1—lung cancer	0.000166	0.000751	CbGpPWpGaD
Cyproterone acetate—Dizziness—Docetaxel—lung cancer	0.000166	0.000274	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	0.000164	0.000745	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—RARB—lung cancer	0.000164	0.000743	CbGpPWpGaD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000162	0.000268	CcSEcCtD
Cyproterone acetate—Discomfort—Doxorubicin—lung cancer	0.000161	0.000266	CcSEcCtD
Cyproterone acetate—Dyspnoea—Methotrexate—lung cancer	0.000161	0.000266	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—NPPA—lung cancer	0.00016	0.000724	CbGpPWpGaD
Cyproterone acetate—Vomiting—Docetaxel—lung cancer	0.000159	0.000263	CcSEcCtD
Cyproterone acetate—Dyspepsia—Methotrexate—lung cancer	0.000159	0.000263	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—CYP2A7—lung cancer	0.000158	0.000717	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—lung cancer	0.000158	0.000716	CbGpPWpGaD
Cyproterone acetate—Rash—Docetaxel—lung cancer	0.000158	0.000261	CcSEcCtD
Cyproterone acetate—Dermatitis—Docetaxel—lung cancer	0.000158	0.000261	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MYC—lung cancer	0.000157	0.000711	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Methotrexate—lung cancer	0.000157	0.000259	CcSEcCtD
Cyproterone acetate—Headache—Docetaxel—lung cancer	0.000157	0.000259	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—lung cancer	0.000156	0.000709	CbGpPWpGaD
Cyproterone acetate—Oedema—Doxorubicin—lung cancer	0.000156	0.000258	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Methotrexate—lung cancer	0.000156	0.000258	CcSEcCtD
Cyproterone acetate—Fatigue—Methotrexate—lung cancer	0.000156	0.000257	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	0.000155	0.000704	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—SKI—lung cancer	0.000155	0.000702	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SDC4—lung cancer	0.000155	0.000701	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—EP300—lung cancer	0.000155	0.000701	CbGpPWpGaD
Cyproterone acetate—Shock—Doxorubicin—lung cancer	0.000154	0.000254	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—lung cancer	0.000153	0.000696	CbGpPWpGaD
Cyproterone acetate—Nervous system disorder—Doxorubicin—lung cancer	0.000153	0.000253	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Doxorubicin—lung cancer	0.000153	0.000253	CcSEcCtD
Cyproterone acetate—Tachycardia—Doxorubicin—lung cancer	0.000152	0.000252	CcSEcCtD
Cyproterone acetate—Skin disorder—Doxorubicin—lung cancer	0.000152	0.000251	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	0.000151	0.000685	CbGpPWpGaD
Cyproterone acetate—Hyperhidrosis—Doxorubicin—lung cancer	0.000151	0.00025	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—TP53—lung cancer	0.00015	0.000679	CbGpPWpGaD
Cyproterone acetate—Anorexia—Doxorubicin—lung cancer	0.000149	0.000246	CcSEcCtD
Cyproterone acetate—Nausea—Docetaxel—lung cancer	0.000149	0.000246	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Methotrexate—lung cancer	0.000149	0.000246	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	0.000148	0.00067	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal pain—Methotrexate—lung cancer	0.000148	0.000244	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.000146	0.000664	CbGpPWpGaD
Cyproterone acetate—Hypotension—Doxorubicin—lung cancer	0.000146	0.000242	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—lung cancer	0.000145	0.000657	CbGpPWpGaD
Cyproterone acetate—Urticaria—Methotrexate—lung cancer	0.000143	0.000237	CcSEcCtD
Cyproterone acetate—Body temperature increased—Methotrexate—lung cancer	0.000143	0.000236	CcSEcCtD
Cyproterone acetate—Abdominal pain—Methotrexate—lung cancer	0.000143	0.000236	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—RRM1—lung cancer	0.000141	0.000639	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTA3—lung cancer	0.000141	0.000639	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	0.00014	0.000633	CbGpPWpGaD
Cyproterone acetate—Dyspnoea—Doxorubicin—lung cancer	0.000139	0.00023	CcSEcCtD
Cyproterone acetate—Dyspepsia—Doxorubicin—lung cancer	0.000138	0.000228	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—HSPB1—lung cancer	0.000137	0.000622	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Doxorubicin—lung cancer	0.000136	0.000225	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000135	0.000223	CcSEcCtD
Cyproterone acetate—Fatigue—Doxorubicin—lung cancer	0.000135	0.000223	CcSEcCtD
Cyproterone acetate—Constipation—Doxorubicin—lung cancer	0.000134	0.000221	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL6—lung cancer	0.000133	0.000606	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Methotrexate—lung cancer	0.000133	0.00022	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—B4GALT5—lung cancer	0.000132	0.000601	CbGpPWpGaD
Cyproterone acetate—Asthenia—Methotrexate—lung cancer	0.000129	0.000214	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—GSTA4—lung cancer	0.000129	0.000584	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—TP53—lung cancer	0.000129	0.000584	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Doxorubicin—lung cancer	0.000129	0.000213	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	0.000128	0.000582	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal pain—Doxorubicin—lung cancer	0.000128	0.000211	CcSEcCtD
Cyproterone acetate—Pruritus—Methotrexate—lung cancer	0.000128	0.000211	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—CREBBP—lung cancer	0.000126	0.000573	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—AKT1—lung cancer	0.000126	0.000573	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	0.000126	0.000571	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTA2—lung cancer	0.000126	0.000569	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—RARB—lung cancer	0.000124	0.000563	CbGpPWpGaD
Cyproterone acetate—Urticaria—Doxorubicin—lung cancer	0.000124	0.000205	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	0.000124	0.000563	CbGpPWpGaD
Cyproterone acetate—Abdominal pain—Doxorubicin—lung cancer	0.000123	0.000204	CcSEcCtD
Cyproterone acetate—Body temperature increased—Doxorubicin—lung cancer	0.000123	0.000204	CcSEcCtD
Cyproterone acetate—Diarrhoea—Methotrexate—lung cancer	0.000123	0.000204	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—GSTA1—lung cancer	0.000121	0.000549	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NPPA—lung cancer	0.000121	0.000549	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NOTCH3—lung cancer	0.000121	0.000548	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ABCC3—lung cancer	0.00012	0.000543	CbGpPWpGaD
Cyproterone acetate—Dizziness—Methotrexate—lung cancer	0.000119	0.000197	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—IL6—lung cancer	0.000117	0.000532	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AKR1C1—lung cancer	0.000116	0.000526	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Doxorubicin—lung cancer	0.000115	0.00019	CcSEcCtD
Cyproterone acetate—Vomiting—Methotrexate—lung cancer	0.000115	0.00019	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—JUNB—lung cancer	0.000114	0.000519	CbGpPWpGaD
Cyproterone acetate—Rash—Methotrexate—lung cancer	0.000114	0.000188	CcSEcCtD
Cyproterone acetate—Dermatitis—Methotrexate—lung cancer	0.000114	0.000188	CcSEcCtD
Cyproterone acetate—Headache—Methotrexate—lung cancer	0.000113	0.000187	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—UGT1A1—lung cancer	0.000113	0.000511	CbGpPWpGaD
Cyproterone acetate—Asthenia—Doxorubicin—lung cancer	0.000112	0.000185	CcSEcCtD
Cyproterone acetate—Pruritus—Doxorubicin—lung cancer	0.000111	0.000183	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—lung cancer	0.000109	0.000493	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GNG11—lung cancer	0.000109	0.000493	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—APOA1—lung cancer	0.000108	0.00049	CbGpPWpGaD
Cyproterone acetate—Nausea—Methotrexate—lung cancer	0.000107	0.000177	CcSEcCtD
Cyproterone acetate—Diarrhoea—Doxorubicin—lung cancer	0.000107	0.000177	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	0.000105	0.000475	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—HSPB1—lung cancer	0.000104	0.000472	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ALDOA—lung cancer	0.000103	0.000469	CbGpPWpGaD
Cyproterone acetate—Dizziness—Doxorubicin—lung cancer	0.000103	0.000171	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL6—lung cancer	0.000101	0.000459	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NCOA3—lung cancer	0.0001	0.000455	CbGpPWpGaD
Cyproterone acetate—Vomiting—Doxorubicin—lung cancer	9.93e-05	0.000164	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	9.86e-05	0.000447	CbGpPWpGaD
Cyproterone acetate—Rash—Doxorubicin—lung cancer	9.85e-05	0.000163	CcSEcCtD
Cyproterone acetate—Dermatitis—Doxorubicin—lung cancer	9.84e-05	0.000163	CcSEcCtD
Cyproterone acetate—Headache—Doxorubicin—lung cancer	9.79e-05	0.000162	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—ADCY1—lung cancer	9.76e-05	0.000443	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ABCG2—lung cancer	9.76e-05	0.000443	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—CREBBP—lung cancer	9.59e-05	0.000435	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ENO2—lung cancer	9.57e-05	0.000434	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HPGDS—lung cancer	9.57e-05	0.000434	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PPP2R1B—lung cancer	9.51e-05	0.000432	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—POMC—lung cancer	9.39e-05	0.000426	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTT1—lung cancer	9.29e-05	0.000421	CbGpPWpGaD
Cyproterone acetate—Nausea—Doxorubicin—lung cancer	9.28e-05	0.000154	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—GCLC—lung cancer	9.18e-05	0.000416	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP2A6—lung cancer	9.18e-05	0.000416	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NOTCH3—lung cancer	9.17e-05	0.000416	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	9.14e-05	0.000415	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ENO1—lung cancer	8.7e-05	0.000395	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—JUNB—lung cancer	8.69e-05	0.000394	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	8.67e-05	0.000393	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—lung cancer	8.56e-05	0.000388	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—ERCC2—lung cancer	8.31e-05	0.000377	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP2E1—lung cancer	7.8e-05	0.000354	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NQO1—lung cancer	7.72e-05	0.00035	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	7.56e-05	0.000343	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—MYC—lung cancer	7.5e-05	0.00034	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	7.49e-05	0.00034	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—STK11—lung cancer	6.96e-05	0.000316	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.53e-05	0.000296	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTP1—lung cancer	6.44e-05	0.000292	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—ERCC2—lung cancer	6.31e-05	0.000286	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CAT—lung cancer	6.26e-05	0.000284	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.23e-05	0.000282	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ABCB1—lung cancer	6.09e-05	0.000276	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—CREBBP—lung cancer	6.09e-05	0.000276	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—TYMS—lung cancer	5.98e-05	0.000271	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTM1—lung cancer	5.91e-05	0.000268	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—MYC—lung cancer	5.69e-05	0.000258	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP1A1—lung cancer	5.61e-05	0.000254	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ERCC2—lung cancer	5.56e-05	0.000252	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—APOA1—lung cancer	4.81e-05	0.000218	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—CREBBP—lung cancer	4.62e-05	0.000209	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.61e-05	0.000209	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CG—lung cancer	4.39e-05	0.000199	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—POMC—lung cancer	4.18e-05	0.00019	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CREBBP—lung cancer	4.07e-05	0.000185	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CD—lung cancer	3.86e-05	0.000175	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ALB—lung cancer	3.81e-05	0.000173	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—MAPK3—lung cancer	3.71e-05	0.000168	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—MYC—lung cancer	3.61e-05	0.000164	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CB—lung cancer	3.37e-05	0.000153	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTGS2—lung cancer	3.33e-05	0.000151	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTEN—lung cancer	2.91e-05	0.000132	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—MAPK3—lung cancer	2.82e-05	0.000128	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—EP300—lung cancer	2.77e-05	0.000126	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—MYC—lung cancer	2.74e-05	0.000124	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—AKT1—lung cancer	2.5e-05	0.000114	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CA—lung cancer	2.05e-05	9.31e-05	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—AKT1—lung cancer	1.9e-05	8.62e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AKT1—lung cancer	1.68e-05	7.6e-05	CbGpPWpGaD
